Article | October 9, 2019

Parkinson's: Why Has Disease Modification Failed — And What Now?

Brain 450x300

Researchers have made many attempts at disease modification as they pursue breakthroughs in treating Parkinson’s disease, but so far without success. Why have these efforts failed, and what’s next in treating this degenerative disorder that affects an estimated 10 million people worldwide?

We tackled these questions in a Premier Research webcastThe Potential for Disease Modifying Therapies in Parkinson’s Disease. In this blog post, the second of three on the subject, we examine these past attempts, why they failed, and what targets are currently being pursued.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: